Lilja H, Blanc P, Demetriou A A, Rozga J
Department of Surgery, Burns and Allen Research Institute, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA 90048, USA.
Cell Transplant. 1998 May-Jun;7(3):257-66. doi: 10.1177/096368979800700304.
Hepatocyte transplantation is a promising alternative to orthotopic liver transplantation in experimental animal models with genetic disorders of liver metabolism and liver failure. Fetal hepatocytes have several characteristics that make them potentially suitable as donor cells. In contrast to adult hepatocytes, fetal hepatocytes are thought to be highly proliferative, which may facilitate engraftment, expansion of transplanted cell population, and gene transfer requiring active DNA synthesis. The present study was undertaken to evaluate the proliferative capacity of fetal and adult rat hepatocytes under standardized culture conditions. Fetal (20 days of gestation) and adult hepatocytes were cultured in serum-free media at low densities and treated with growth factors. Proliferation was assessed by [3H]-thymidine incorporation and cell cycle analysis by flow cytometry. In nonstimulated cells, DNA synthesis at 4 h was about x100 higher and after 10 days in culture x20 higher in fetal compared to adult hepatocytes. When epidermal growth factor (EGF) was added, maximal DNA synthesis in fetal hepatocytes was seen at 48 h, whereas in adult hepatocytes at 72 h. For adult hepatocytes, the average increase compared to untreated cells was x13.8 with EGF, x18.5 with transforming growth factor alpha (TGF-alpha), and x7.6 with hepatocyte growth factor (HGF). For fetal hepatocytes, the increase was twofold with either EGF, TGF-alpha or HGF. EGF-, TGF-alpha- and HGF-dependent DNA synthesis was inhibited by transforming growth factor beta-1 (TGF-beta1) in both fetal and adult hepatocyte cultures; this antiproliferative effect was significantly stronger in adult hepatocyte cultures. With cyclosporine, EGF-, TGF-alpha- and HGF-dependent DNA synthesis in fetal hepatocyte cultures decreased by 36-46%, whereas in adult hepatocytes by 19-27 %. These results show that in contrast to adult hepatocytes, fetal hepatocytes have high spontaneous proliferative activity independently of growth factors and are relatively resistant to the inhibitory effect of TGF-beta1. It was also found that cyclosporine suppresses proliferation of cultured fetal hepatocytes.
在患有肝脏代谢遗传疾病和肝衰竭的实验动物模型中,肝细胞移植是原位肝移植的一种有前景的替代方法。胎儿肝细胞具有若干使其有可能适合作为供体细胞的特性。与成年肝细胞相比,胎儿肝细胞被认为具有高度增殖性,这可能有助于移植、移植细胞群体的扩增以及需要活跃DNA合成的基因转移。本研究旨在评估在标准化培养条件下胎儿和成年大鼠肝细胞的增殖能力。将胎儿(妊娠20天)和成年肝细胞以低密度接种于无血清培养基中,并用生长因子处理。通过[3H] - 胸腺嘧啶核苷掺入评估增殖,并通过流式细胞术进行细胞周期分析。在未刺激的细胞中,培养4小时时胎儿肝细胞的DNA合成比成年肝细胞高约100倍,培养10天后高20倍。添加表皮生长因子(EGF)时,胎儿肝细胞在48小时时出现最大DNA合成,而成年肝细胞在72小时时出现。对于成年肝细胞,与未处理细胞相比,EGF使其平均增加13.8倍,转化生长因子α(TGF - α)使其增加18.5倍,肝细胞生长因子(HGF)使其增加7.6倍。对于胎儿肝细胞,EGF、TGF - α或HGF均可使其增加两倍。在胎儿和成年肝细胞培养物中,转化生长因子β - 1(TGF - β1)均抑制EGF、TGF - α和HGF依赖性DNA合成;这种抗增殖作用在成年肝细胞培养物中明显更强。使用环孢素时,胎儿肝细胞培养物中EGF、TGF - α和HGF依赖性DNA合成减少36 - 46%,而成年肝细胞中减少19 - 27%。这些结果表明,与成年肝细胞相比,胎儿肝细胞具有独立于生长因子的高自发增殖活性,并且对TGF - β1的抑制作用相对抗性。还发现环孢素可抑制培养的胎儿肝细胞的增殖。